Triclocarbon Category I Antibacterial Efficacy Supported By Bayer Studies
This article was originally published in The Tan Sheet
Triclocarbon in concentrations up to 1.5% should be included as a Category I active ingredient in the healthcare antiseptic tentative final monograph, Bayer advises FDA in a 1Dec. 28 citizen petition
You may also be interested in...
FDA should consider new safety data supporting Category I (safe and effective) status for triclosan in the OTC Tentative Final Monograph for Health Care Antiseptic Drug Products, CIBA Specialty Chemicals and an alliance of six triclosan manufacturers/marketers state in a Sept. 13 citizen petition.
Labeling of antibacterial consumer hand and body products should include a "qualified" warning statement regarding children's use of such items, the Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association suggest in a citizen petition filed with FDA April 2.
Perrigo promotes in pricing, planning